Jump to main content
Jump to site search

Issue 27, 2020
Previous Article Next Article

Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

Author affiliations

Abstract

Amyloid diseases are global epidemics with no cure currently available. In the past decade, the use of engineered nanomaterials as inhibitors or probes against the pathogenic aggregation of amyloid peptides and proteins has emerged as a new frontier in nanomedicine. In this Minireview, we summarize for the first time the pivotal role of chemical synthesis in enabling the development of this multidisciplinary field.

Graphical abstract: Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

Back to tab navigation

Article information


Submitted
04 Jun 2020
Accepted
30 Jun 2020
First published
30 Jun 2020

Nanoscale, 2020,12, 14422-14440
Article type
Minireview

Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases

N. Andrikopoulos, Y. Li, L. Cecchetto, A. Nandakumar, T. Da Ros, T. P. Davis, K. Velonia and P. C. Ke, Nanoscale, 2020, 12, 14422
DOI: 10.1039/D0NR04273K

Social activity

Search articles by author

Spotlight

Advertisements